Session: MON 37-82-Pheochromocytoma & Paraganglioma
Poster Board MON-80
Clinical case: A 58‐year schizophrenic woman with malignant paraganglioma refused chemotherapy because of pregnancy delusion. CT, PET, MIBG and bone scan indicated metastases to chest wall, lumbar vertebrae and liver confirming the diagnosis of malignant paraganglioma in 2007. Elevated plasma norepinephrine secretion (18220 pg/mL, normal range: 100-450 pg/mL) and elevated 24hr urinary norepinephrine secretion (3789 microgram/day, normal range: 26-121 microgram/day) were observed. On the other hand, her plasma epinephrine and 24hr urinary epinephrine secretion were normal. Her blood pressure has been normal for more than 6 years. Her 24-hour ambulatory blood pressure monitoring (ABPM) and pulse wave velocity (PWV) were normal. There was no need of alpha-adrenergic blockade with antihypertensive drug for her. She has continued to take olanzapine as antipsychotics for schizophrenia.
Clinical Lesson and Conclusion: This is the first case demonstrating the possible role of alpha-adrenergic blockade of antipsychotic drug for malignant paraganglioma. Olanzapine has a high affinity for dopamine, serotonin, histamine, cholinergic muscarinic and alpha-adrenergic receptors. Antipsychotics with a high affinity for alpha-adrenergic receptors have a potential to prevent hypertensive complications of malignant paraganglioma.
Nothing to Disclose: MI
*Please take note of The Endocrine Society's News Embargo Policy at http://www.endo-society.org/endo2013/media.cfm
See more of: Abstracts - Orals, Featured Poster Presentations, and Posters